Pascack Valley Dental Practice Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 449 Old Hook Rd, Emerson, NJ 07630 Phone: 201-265-8600 |
Emerson Family Dental Care Dentist Medicare: Not Enrolled in Medicare Practice Location: 466 Old Hook Rd, Suite 243, Emerson, NJ 07630 Phone: 201-261-6688 Fax: 201-261-4110 |
Smiles By Bergen Dental Emerson Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 310 Main St, Emerson, NJ 07630 Phone: 201-261-3364 Fax: 201-265-9358 |
Christopher Sonn Dds Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 466 Old Hook Rd Ste 24b, Emerson, NJ 07630 Phone: 917-771-4212 |
Emerson Dental Associates Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 110 Kinderkamack Rd, Suite 2a, Emerson, NJ 07630 Phone: 201-262-3663 |
Archer M. Katz Dmd Pa Dentist Medicare: Not Enrolled in Medicare Practice Location: 310 Main St, Emerson, NJ 07630 Phone: 201-261-3364 Fax: 201-265-9358 |
News Archive
Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center.
In September 2009, the Kansas City District Office of the Food and Drug Administration (FDA) submitted a recommendation of approval to the Center for Drug Evaluation and Research for The University of Iowa Pharmaceuticals (UIP) to manufacture and test an aseptically filled, sterile prescription drug product for a commercial client. The drug product contains a new chemical entity and is a sterile solution that is aseptically filled into vials.
By studying nerve and liver cells grown from patient-derived induced pluripotent stem cells (iPSCs), Whitehead Institute researchers have identified a potential dual-pronged approach to treating Niemann-Pick type C (NPC) disease, a rare but devastating genetic disorder.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the search for an improved method of treating atrial fibrillation (AF) will be unaffected by the recent mixed decision by the Food and Drug Administration (FDA) panel on Medtronic's phased radiofrequency (RF) pulmonary vein ablation catheter (PVAC).
› Verified 8 days ago